# CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia

> **NCT04452396** · NA · TERMINATED · sponsor: **Barts & The London NHS Trust** · enrollment: 7 (actual)

## Conditions studied

- Hypoglycemia, Reactive
- Hypoglycaemia Night
- Hypoglycemia Non-Diabetic
- Hypoglycemia Unawareness
- Insulinoma
- Insulinoma; Malignant, Pancreas
- Insulin Hypoglycemia
- Insulin Resistance
- Spontaneous Hypoglycemia
- Neuro Endocrine Tumours

## Interventions

- **DEVICE:** use of continuous glucose monitoring

## Key facts

- **NCT ID:** NCT04452396
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-01
- **Primary completion:** 2020-03-01
- **Final completion:** 2023-01-31
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Due to the Covid crisis: clinical changes in staff, bed pressures and time restraints.
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04452396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04452396, "CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04452396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*